5.32
5.32 (-0.20%)
As of Feb 24, 2021
Viracta Therapeutics, Inc. [SNSS]
Source:
Company Overview
Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide.
| Country | United States |
| Headquarters | cardiff, california |
| Phone Number | ( 858 ) 400-8470 |
| Industry | manufacturing |
| CEO | Mark Rothera |
| Website | www.viracta.com |